Caffeine and the Methylxanthines

  • Robin B. Kanarek
  • Robin Marks-Kaufman


Caffeine is the world’s most popular drug and is taken regularly in coffee, tea, cocoa, cola drinks, chocolate, and over-the-counter medicines.


Attention Deficit Hyperactivity Disorder Panic Disorder Caffeine Intake Caffeine Consumption Premenstrual Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised. Washington, D.C.: American Psychiatric Association.Google Scholar
  2. Barone, J. J. and H. Roberts. 1984. Human consumption of caffeine. In Caffeine, ed. P. B. Dews, pp. 59–76. New York: Springer Verlag.CrossRefGoogle Scholar
  3. Boulenger, J. P. and T. W. Uhde. 1982. Caffeine consumption and anxiety: Pre-liminary results of a survey comparing patients with anxiety disorders and normal controls. Psychopharmacology Bulletin 18: 53–57.Google Scholar
  4. Boulenger, J. P., T. W. Uhde, E. A. Wolff, III, and R. M. Post. 1984. Increased sensitivity to caffeine in patients with panic disorder. Archives of General Psychiatry 41: 1067–1071.Google Scholar
  5. Clementz, G. L. and J. W. Dailey. 1988. Psychotropic effects of caffeine. Ameri¬can Family Physician 37 (5): 167–172.Google Scholar
  6. Clubley, M., C. E. Bye, T. A. Henson, A. W. Peck, and C. J. Riddington. 1979. Effects of caffeine and cyclizine alone and in combination on human performance, subjective effects and EEG activity. British Journal of Clinical Pharmacology 7: 157–163.Google Scholar
  7. Conners, C. K. 1979. The acute effects of caffeine on evoked response, vigilance, and activity level in hyperkinetic children. Journal of Abnormal Child Psychology 7: 145–151.CrossRefGoogle Scholar
  8. Curatolo, P. W. and D. Robertson. 1983. The health consequences of caffeine. Annals of Internal Medicine 98: 641–653.Google Scholar
  9. Dawber, T. R., W. B. Kannel, and T. Gordon. 1974. Coffee and cardiovascular disease: Observations from the Framingham study. New England Journal of Medicine 291: 871–874.CrossRefGoogle Scholar
  10. Dews, P. B. 1982. Caffeine. Annual Review of Nutrition 2: 323–341.CrossRefGoogle Scholar
  11. Eaton, W. W. and J. McLeod. 1984. Consumption of coffee or tea and symptoms of anxiety. American Journal of Public Health 74: 66–68.CrossRefGoogle Scholar
  12. Fernstrom, J. D. and M. H. Fernstrom. 1984. Effects of caffeine on monoamine neurotransmitters in the central and peripheral nervous system. In Caffeine, ed. P. B. Dews, pp. 107–118. New York: Springer Verlag.CrossRefGoogle Scholar
  13. Gilbert, R. M. 1976. Caffeine as a drug of abuse. In Research Advances in Alcohol and Drug Problems, ed. R. J. Gibbins, Y. Israel, H. Kalant, R. E. Popham, W. Schmidt, and R. G. Smart, pp. 49–176. New York: Wiley.Google Scholar
  14. Gilbert, R. M. 1981. Caffeine: Overview and anthology. In Nutrition and Behavior, ed. S. A. Miller, pp. 145–166. Philadelphia: Frankl in Institute.Google Scholar
  15. Gilbert, R. M. 1984. Caffeine consumption. In Methylxanthine Beverages and Foods: Chemistry, Consumption, and Health Effects, ed. G. A. Spiller, pp. 185– 213. New York: Alan R. Liss.Google Scholar
  16. Gilliland, K. and D. Andress. 1981. Ad lib caffeine consumption, symptoms of caffeinism and academic performance. American Journal of Psychiatry 138: 512–514.CrossRefGoogle Scholar
  17. Goldstein, A., S. Kaizer, and R. Warren. 1965. Psychotropic effects of caffeine in man: II. Alertness, psychomotor coordination and mood. Journal of Pharmacol¬ogy and Experimental Therapeutics 150: 146–151.Google Scholar
  18. Goldstein, A., R. Warren, and S. Kaizer. 1965. Psychotropic effects of caffeine in man: I. Individual differences in sensitivity to caffeine-induced wakefulness. Jour¬nal of Pharmacology and Experimental Therapeutics 149: 156–159.Google Scholar
  19. Graham, D. M. 1978. Caffeine: Its identity, dietary sources, intake and biological effects. Nutrition Reviews 36 (4): 97–102.CrossRefGoogle Scholar
  20. Greden, J. F., P. Fontaine, M. Lubetsky, and K. Chamberlin. 1978. Anxiety and depression associated with caffeinism among psychiatric inpatients. American Journal of Psychiatry 135: 963–966.Google Scholar
  21. Grice, H. C. 1984. The carcinogenic potential of caffeine. In Caffeine, ed. P. B. Dews, pp. 201–220. New York: Springer Verlag.CrossRefGoogle Scholar
  22. Griffiths, R. R., G. E. Bigelow, and I. A. Liebson. 1986. Human coffee drinking: Reinforcing and physical dependence-producing effects of caffeine. Journal of Pharmacology and Experimental Therapeutics 239: 416–425.Google Scholar
  23. Griffiths, R. R. and P. P. Woodson. 1988. Caffeine physical dependence: A review of human and laboratory animal studies. Psychopharmacology 94: 437–451.CrossRefGoogle Scholar
  24. Heyden, S. and L. H. Muhlbaier. 1984. Prospective study of “fibrocystic breast disease” and caffeine consumption. Surgery 96: 479–484.Google Scholar
  25. Hirsh, K. 1984. Central nervous system pharmacology of the dietary methyl- xanthines. In Methlyxanthine Beverages and Foods: Chemistry, Consumption and Health Effects, ed. G. A. Spiller. pp. 235–301. New York: Alan R. Liss.Google Scholar
  26. Huestis, R. D., L. E. Arnold, and D. J. Smeltzer. 1975. Caffeine versus methylphe- nidate and d-amphetamine in minimal brain dysfunction: A double-blind compari¬son. American Journal of Psychiatry 132: 868–870.Google Scholar
  27. Jick, H., O. S. Miettinen, R. K. Neff, S. Shapiro, O. P. Heinonen, and D. Slone. 1973. Coffee and myocardial infarction. New England Journal of Medicine 289: 63–67.CrossRefGoogle Scholar
  28. Leonard, T. K., R. R. Watson, and M. E. Mohs. 1987. The effects of caffeine on various body systems: A review. Journal of the American Dietetic Association 87: 1048–1053.Google Scholar
  29. Leviton, A. 1988. Caffeine consumption and the risks of reproductive hazards. Journal of Reproductive Medicine 33: 175–178.Google Scholar
  30. Lieberman, H. R., R. J. Wurtman, G. G. Emde, C. Roberts, and I. L. G. Coviella. 1987. The effects of low doses of caffeine on human performance and mood. Psychopharmacology 92: 308–312.CrossRefGoogle Scholar
  31. Linn, S., S. C. Schoenbaum, R. R. Monson, B. Rosner, P. G. Stubblefield, and K. J. Ryan. 1982. No association between coffee consumption and adverse out¬comes of pregnancy. New England Journal of Medicine 306: 141–145.CrossRefGoogle Scholar
  32. Loke, W. H. 1988. Effects of caffeine on mood and memory. Physiology and Behavior 44: 367–372.CrossRefGoogle Scholar
  33. Loke, W. H., J. V. Hinrichs, and M. M. Ghoneim. 1985. Caffeine and diazepam: Separate and combined effects on mood, memory, and psychomotor performance. Psychopharmacology 87: 344–350.CrossRefGoogle Scholar
  34. MacMahon, B., S. Yen, D. Trichopoulos, K. Warren, and G. Nardi. 1981. Coffee and cancer of the pancreas. New England Journal of Medicine 304: 630–633.CrossRefGoogle Scholar
  35. Marshall, J., S. Graham, and M. Swanson. 1982. Caffeine consumption and benign breast disease: A case-control comparison. American Journal of Public Health 72: 610–612.CrossRefGoogle Scholar
  36. McKim, W. A. 1986. Drugs and Behavior, Englewood Cliffs, NJ: Prentice-Hall.Google Scholar
  37. Minton, J. P., M. K. Foecking, D. J. T. Webster, and R. H. Matthews. 1979. Caffeine, cyclic nucleotides, and breast disease. Surgery 86: 105–109.Google Scholar
  38. Rail, T. W. 1985. Central nervous system stimulants: The methlyxanthines. In The Pharmacological Basis of Therapeutics, ed. A. G. Gilman, L. S. Goodman, T. W. Rail, and F. Murad, pp. 589–603. New York: Macmillan.Google Scholar
  39. Ray, O. 1978. Drugs, Society and Human Behavior. Saint Louis, MO: C. V. Mosby.Google Scholar
  40. Roache, J. D. and R. R. Griffiths. 1987. Interactions of diazepam and caffeine: Behavioral and subjective dose effects in humans. Pharmacology, Biochemistry and Behavior 26: 801–812.CrossRefGoogle Scholar
  41. Rohan, T. E., M. G. Cook, and A. J. McMichael. 1989. Methylxanthines and benign proliferative epithelial disorders of the breast in women. International Journal of Epidemiology 18: 626–633.CrossRefGoogle Scholar
  42. Rosenberg, L., A. A. Mitchell, S. Shapiro, and D. Slone. 1982. Selected birth defects relating to caffeine-containing beverages. Journal of the American Medical Association 247: 1429–1432.CrossRefGoogle Scholar
  43. Rosenberg, L., D. Slone, S. Shapiro, D. Kaufman, P. Stolley, and O. Miettinen. 1980. Coffee drinking and myocardial infarction in young women. American Jour¬nal of Epidemiology 111: 675–681.Google Scholar
  44. Rossignol, A. M. 1985. Caffeine-containing beverages and premenstrual syndrome in young women. American Journal of Public Health 75: 1335–1337.CrossRefGoogle Scholar
  45. Rumsey, J. M. and J. L. Rapoport. 1983. Assessing behavioral and cognitive effects of diet in pediatric populations. In Nutrition and the Brain, vol. 6, ed. R. J. Wurtman and J. J. Wurtman, pp. 101–161. New York: Raven Press.Google Scholar
  46. Schnackenberg, R. C. 1973. Caffeine as a substitute for schedule II stimulants in hyperkinetic children. American Journal of Psychiatry 130: 796–798.Google Scholar
  47. Snyder. S. H. 1984. Adenosine as a mediator of the behavioral effects of xanthines. In Caffeine, ed. P. B. Dews, pp. 129–141. New York: Springer Verlag.CrossRefGoogle Scholar
  48. Weiss, B. and V. G. Laties. 1962. Enhancement of human performance by caffeine and the amphetamines. Pharmacology Reviews 14: 1–36.Google Scholar
  49. Wilson, J. G. and W. J. Scott. 1984. The teratogenic potential of caffeine in laboratory animals. In Caffeine, ed. P. B. Dews, pp. 165–187. New York: Springer Verlag.CrossRefGoogle Scholar
  50. Whorton, J. C. 1982. Crusaders for Fitness. Princeton, NJ: Princeton University Press.Google Scholar
  51. Zwyghuizen-Doorenbos, A., T. A. Roehrs, L. Lipschutz, V. Timms, and T. Roth. 1990. Effects of caffeine on alertness. Psychopharmacology 100: 36–39.CrossRefGoogle Scholar

Copyright information

© Van Nostrand Reinhold 1991

Authors and Affiliations

  • Robin B. Kanarek
    • 1
  • Robin Marks-Kaufman
    • 1
  1. 1.Tufts UniversityMedfordUSA

Personalised recommendations